This research develops an AI model that combines thyroid ultrasound imaging with genetic testing to improve diagnosis of indeterminate thyroid nodules. By integrating molecular and imaging data, the model helps distinguish benign from cancerous nodules more accurately, reducing unnecessary surgeries and improving clinical decision-making for thyroid cancer patients.

This research develops soft, tissue-like implantable sensors capable of monitoring molecular signals inside the body in real time. By combining high-performance electronics with flexible, biocompatible materials, these devices could detect inflammation, stress, or organ damage before symptoms arise, enabling earlier diagnosis and more personalized healthcare.

This research investigates the genetic mechanisms underlying polycystic ovary syndrome (PCOS), a condition affecting one in ten women and the leading cause of female infertility. By studying thousands of genetic variants across multiple cell types, the project aims to identify the biological causes of PCOS and develop targeted treatments.

This research develops engineered ultrasonic reporters that allow ultrasound imaging to detect molecular activity rather than only anatomical structure. By targeting biological signals associated with cancer progression and cellular communication, the work aims to distinguish aggressive disease earlier and improve precision medicine through real-time, noninvasive monitoring of underlying cellular behavior.

This research uses wearable data and AI to detect disease earlier by analyzing continuous health signals rather than isolated clinical snapshots. By personalizing models to individual baselines, the system identifies subtle changes linked to conditions like infections, heart issues, and mental health crises, enabling earlier intervention and potentially saving lives.

This research challenges the one-size-fits-all approach to obesity by comparing childhood- and adult-onset cases. Through physiological testing before and after weight loss, it examines differences in inflammation, metabolism, and fitness. Findings aim to support personalised treatments, improving patient outcomes and reducing the broader healthcare burden associated with obesity.

This research uses spatial transcriptomics to map interactions between T cells, cancer cells, and immunosuppressive cells in tumours. Findings suggest cancer suppresses immune responses by surrounding and weakening T cells. The work aims to improve immunotherapy and enable personalised cancer treatment through detailed tumour mapping.

This research develops digital twin systems to personalise robotic exoskeleton movement. By integrating biomechanical modelling with real-time robotic control, it enables adaptive, user-specific walking patterns. The approach aims to improve rehabilitation outcomes by making assistive devices more natural, responsive, and aligned with individual movement needs.

This research engineers immune T cells to better fight ovarian cancer. By modifying them to recognize tumor-specific proteins and resist cancer’s suppressive signals, the project strengthens the body’s natural defenses. The goal is to improve immunotherapy effectiveness, overcome tumor resistance, and increase survival rates for women facing this deadly disease.